Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) Price, Holdings, & News

ETF Overview

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.

Key Stats

• Today's Range: $28.40 to $28.62
• 50-Day Range: $26.75 to $29.20
• 52-Week Range: $25.32 to $36.03
• Volume: 1,498 shs
• Average Volume: 9,583 shs
• Market Capitalization: $54.11 million
• Assets Under Management: $50.84 million
• Dividend Yield: 1.62%
• Net Expense Ratio: 0.75%
• Aggregate Rating: Moderate Buy

HRTS ETF - Frequently Asked Questions

How have HRTS shares performed this year?

Tema GLP-1, Obesity & Cardiometabolic ETF's stock was trading at $28.87 at the start of the year. Since then, HRTS shares have decreased by 1.4% and is now trading at $28.48.
View the best growth stocks for 2025 here.

Who are Tema GLP-1, Obesity & Cardiometabolic ETF's major shareholders?

Tema GLP-1, Obesity & Cardiometabolic ETF's top institutional investors include Sterling Investment Advisors Ltd. (9.40%) and Flow Traders U.S. LLC (2.97%).

How do I buy shares of Tema GLP-1, Obesity & Cardiometabolic ETF?

Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Tema GLP-1, Obesity & Cardiometabolic ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tema GLP-1, Obesity & Cardiometabolic ETF investors own include Scilex (SCLX), Rigetti Computing (RGTI), Pfizer (PFE), BlackBerry (BB), Butterfly Network (BFLY), BioNTech (BNTX) and

Fund Details

• Issuer: Tema Global
• Fund Name: Tema GLP-1, Obesity & Cardiometabolic ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NASDAQ
• Current Symbol: NASDAQ:HRTS
• Inception Date: 11/20/2023
• Fund Manager: David Song, Yuri Khodjamirian
• Previous Symbol: NASDAQ:HRTS
• Web: N/A
• Phone: N/A

Fund Focus

• Asset Class: Equity
• Benchmark: N/A
• Category: Strategy
• Focus: Theme
• Development Level: Blended Development
• Region: Global
• Number of Holdings: 47

Fund Statistics

• Assets Under Management: $50.84 million
• Average Daily Volume: $0.00
• Discount/Premium: -0.05%

Administrator, Advisor and Custodian

• Administrator: U.S. Bancorp Fund Services, LLC
• Advisor: Tema Global Limited
• Custodian: U.S. Bank, N.A.
• Distributor: Foreside Fund Services, LLC
• Transfer Agent: U.S. Bancorp Fund Services, LLC
• Trustee: N/A
• Lead Market Maker: Virtu Financial

Options

• Optionable: N/A
• Short Interest: 1,000 shs

Miscellaneous

• Outstanding Shares: 1,900,000
• Beta: 0.93
• Creation Unit: 10,000
• Creation Fee: $500.00